Is BioMarin Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, BioMarin Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.285 per share. Over the last 1 times between 2022 and 2022, BioMarin Pharmaceutical has paid $0.285 with an average of $0.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for BioMarin Pharmaceutical 10 years ago, but if you had invested on Tuesday 1st of February 2022 when the price was $88.63, you would have made a loss of $-26.47 per share or -29.87%
No, the average daily trading liquidity for BioMarin Pharmaceutical is $5 967 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
BioMarin Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.69, the company's ability to pay off the debt is good. BioMarin Pharmaceutical has a good net profit margin of 11.77% and should have high tolerances against inflation.
We have calculated the inflation risk for BioMarin Pharmaceutical to be low [0.1 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.